Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin nasal spray crossover trial in young children with autism spectrum disorder
ACTRN12611000061932Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Sydney. Primary endpoints: Positive social interaction and Severity of repetitive behavior. Started Dec 2010; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12611000061932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000061932.